TechCare Corp. announced it has signed its first distribution agreement with MWMedical B.V. for TechCare's Novokid lice treatment device, which addresses a $1.8 billion market globally, and a European market estimated to exceed $500 million. The multi-year agreement grants the distributor exclusive distribution rights in the Netherlands in consideration of minimum purchase commitments. The distributor has already placed its first order of Novokid's products, 2,500 kits, which will be available in the Netherlands beginning in mid-February.